Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 209

1.

Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen.

Nagendrakumar SB, Srinivasan VA, Madhanmohan M, Yuvaraj S, Parida S, Di Nardo A, Horsington J, Paton DJ.

Vaccine. 2011 Feb 24;29(10):1906-12. doi: 10.1016/j.vaccine.2010.12.127. Epub 2011 Jan 13.

PMID:
21236232
[PubMed - indexed for MEDLINE]
2.

Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.

Cox SJ, Voyce C, Parida S, Reid SM, Hamblin PA, Hutchings G, Paton DJ, Barnett PV.

Vaccine. 2006 Apr 12;24(16):3184-90. Epub 2006 Jan 30.

PMID:
16488060
[PubMed - indexed for MEDLINE]
3.

Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.

Eblé PL, de Bruin MG, Bouma A, van Hemert-Kluitenberg F, Dekker A.

Vaccine. 2006 Feb 27;24(9):1274-81. Epub 2005 Oct 4.

PMID:
16289709
[PubMed - indexed for MEDLINE]
4.

Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.

Moraes MP, Segundo FD, Dias CC, Pena L, Grubman MJ.

Vaccine. 2011 Nov 28;29(51):9431-40. doi: 10.1016/j.vaccine.2011.10.037. Epub 2011 Oct 24.

PMID:
22027486
[PubMed - indexed for MEDLINE]
6.

Clinical protection, sub-clinical infection and persistence following vaccination with extinction payloads of O1 Manisa Foot-and-Mouth Disease monovalent vaccine and challenge in goats and comparison with sheep.

Madhanmohan M, Nagendrakumar SB, Kumar R, Anilkumar J, Manikumar K, Yuvaraj S, Srinivasan VA.

Res Vet Sci. 2012 Oct;93(2):1050-9. doi: 10.1016/j.rvsc.2011.10.006. Epub 2011 Nov 12.

PMID:
22079173
[PubMed - indexed for MEDLINE]
7.

High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.

Brehm KE, Kumar N, Thulke HH, Haas B.

Vaccine. 2008 Mar 20;26(13):1681-7. doi: 10.1016/j.vaccine.2008.01.038. Epub 2008 Feb 12.

PMID:
18313814
[PubMed - indexed for MEDLINE]
8.

An alternate delivery system improves vaccine performance against foot-and-mouth disease virus (FMDV).

Pandya M, Pacheco JM, Bishop E, Kenney M, Milward F, Doel T, Golde WT.

Vaccine. 2012 Apr 26;30(20):3106-11. doi: 10.1016/j.vaccine.2012.02.049. Epub 2012 Mar 2.

PMID:
22387223
[PubMed - indexed for MEDLINE]
9.

Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.

Fowler VL, Knowles NJ, Paton DJ, Barnett PV.

Vaccine. 2010 Apr 26;28(19):3428-34. doi: 10.1016/j.vaccine.2010.02.074. Epub 2010 Mar 1.

PMID:
20199761
[PubMed - indexed for MEDLINE]
10.

Avidity and subtyping of specific antibodies applied to the indirect assessment of heterologous protection against Foot-and-Mouth Disease Virus in cattle.

Lavoria MÁ, Di-Giacomo S, Bucafusco D, Franco-Mahecha OL, Pérez-Filgueira DM, Capozzo AV.

Vaccine. 2012 Nov 6;30(48):6845-50. doi: 10.1016/j.vaccine.2012.09.011. Epub 2012 Sep 18.

PMID:
23000129
[PubMed - indexed for MEDLINE]
11.

Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.

Mohana Subramanian B, Madhanmohan M, Sriraman R, Chandrasekhar Reddy RV, Yuvaraj S, Manikumar K, Rajalakshmi S, Nagendrakumar SB, Rana SK, Srinivasan VA.

Antiviral Res. 2012 Dec;96(3):288-95. doi: 10.1016/j.antiviral.2012.09.019. Epub 2012 Oct 6.

PMID:
23043941
[PubMed - indexed for MEDLINE]
12.

Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.

Grubman MJ.

Biologicals. 2005 Dec;33(4):227-34. Epub 2005 Nov 14.

PMID:
16289996
[PubMed - indexed for MEDLINE]
13.

Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.

Li X, Liu R, Tang H, Jin M, Chen H, Qian P.

Vaccine. 2008 May 23;26(22):2714-22. doi: 10.1016/j.vaccine.2008.03.020. Epub 2008 Apr 1.

PMID:
18436351
[PubMed - indexed for MEDLINE]
14.

Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.

Dar P, Kalaivanan R, Sied N, Mamo B, Kishore S, Suryanarayana VV, Kondabattula G.

Vaccine. 2013 Jul 18;31(33):3327-32. doi: 10.1016/j.vaccine.2013.05.078. Epub 2013 Jun 2.

PMID:
23735678
[PubMed - indexed for MEDLINE]
15.

Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.

Mattion N, König G, Seki C, Smitsaart E, Maradei E, Robiolo B, Duffy S, León E, Piccone M, Sadir A, Bottini R, Cosentino B, Falczuk A, Maresca R, Periolo O, Bellinzoni R, Espinoza A, Torre JL, Palma EL.

Vaccine. 2004 Oct 22;22(31-32):4149-62.

PMID:
15474705
[PubMed - indexed for MEDLINE]
16.

Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).

Cao Y, Lu Z, Li D, Fan P, Sun P, Bao H, Fu Y, Li P, Bai X, Chen Y, Xie B, Liu Z.

Vet Microbiol. 2014 Jan 31;168(2-4):294-301. doi: 10.1016/j.vetmic.2013.11.023. Epub 2013 Nov 28.

PMID:
24345411
[PubMed - indexed for MEDLINE]
17.

Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the "Protection against Podal Generalisation" test.

Goris N, Maradei E, D'Aloia R, Fondevila N, Mattion N, Perez A, Smitsaart E, Nauwynck HJ, La Torre J, Palma E, De Clercq K.

Vaccine. 2008 Jun 25;26(27-28):3432-7. doi: 10.1016/j.vaccine.2008.04.034. Epub 2008 May 5.

PMID:
18499310
[PubMed - indexed for MEDLINE]
18.

Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.

Blignaut B, Visser N, Theron J, Rieder E, Maree FF.

J Gen Virol. 2011 Apr;92(Pt 4):849-59. doi: 10.1099/vir.0.027151-0. Epub 2010 Dec 22.

PMID:
21177923
[PubMed - indexed for MEDLINE]
Free Article
19.

Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes.

Höhlich BJ, Wiesmüller KH, Haas B, Gerner W, Correa R, Hehnen HR, Schlapp T, Pfaff E, Saalmüller A.

J Gen Virol. 2003 Dec;84(Pt 12):3315-24.

PMID:
14645912
[PubMed - indexed for MEDLINE]
Free Article
20.

Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.

Capozzo AV, Wilda M, Bucafusco D, de los Ángeles Lavoria M, Franco-Mahecha OL, Mansilla FC, Pérez-Filgueira DM, Grigera PR.

Antiviral Res. 2011 Nov;92(2):219-27. doi: 10.1016/j.antiviral.2011.08.006. Epub 2011 Aug 26.

PMID:
21889542
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk